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Background: Although many physiological functions of Coprinus comatus have been reported, there has been no
report on the antinociceptive activity of Coprinus comatus. Therefore, the objective of the present study is to
demonstrate the production, isolation, and biological properties of triglycerides (TFC) of the fermented mushroom
of Coprinus comatus.
Methods: The effects of TFC on cytokines levels, total antioxidant activity, antinociceptive effects in vivo, LD50 and
tactile hyperalgesia were analyzed respectively.
Results: TFC treatment decreased the levels of cytokines and total antioxidant status (TAOS) and inhibited the
acetic acid-induced abdominal constrictions in mice. In addition, TFC reduced CFA-induced tactile hyperalgesia in a
dose-dependent manner and the LD50 of TFC was determined to be 400 mg/kg. However, TFC did not significantly
inhibit the reaction time to thermal stimuli in the hot-plate test.
Conclusions: TFC showed anti-inflammatory, antioxidant, peripheral antinociceptive and antihyperalgesic activity in
various models of inflammatory pain. The data suggest that TFC may be a viable treatment option for inflammatory
pain.Background
Edible fungi have a long history of use in Traditional
Chinese Medicine [1]. Coprinus comatus is a basidio-
mycete fungus claimed to benefit glycaemic control in
diabetes. Many physiological functions of Coprinus
comatus have been reported, such as anti-cancer proper-
ties [2], immunomodulatory [3] and hypoglycemic activ-
ity [4]. Stadler et al. reported that agaricoglycerides, a
new class of fungal secondary metabolites isolated from
several basidiomycetes, showed strong activities against
neurolysin, a protease involved in the regulation of
dynorphin and neurotensin metabolism, and even exhib-
ited moderate analgesic in vivo [5]. The agaricoglycerides
are a new class of fungal secondary metabolites that con-
stitute esters of chlorinated 4-hydroxy benzoic acid and
glycerol. Although the crude extract from Coprinus
comatus was no beneficial effect at lower doses in mice
subjected to acetic-acid writhing test, formalin test and* Correspondence: guojianyou@126.com
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reproduction in any medium, provided the orhot-plate test [6], there has been no report on the anti-
nociceptive activity of agaricoglycerides extract from
Coprinus comatus. Therefore, the objectives of the
present study were to demonstrate the production, isola-
tion, and biological properties of triglycerides of the
fermented mushroom of Coprinus comatus.Methods
Fermented mushroom of coprinus comatus
The seed of Coprinus comatus was purchased from the
Agricultural Culture Collection of China.
First, the seed was grown at 28°C for 5 days on PDA
slants (1,000 mL 20% potato extract liquid +20.0 g
dextrose +20.0 g agar) and then maintained at 4°C in a
refrigerator. Five to six pieces of the mycelia of Copri-
nus comatus were transferred from a slant into 250 mL
Erlenmeyer flasks containing 100 mL liquid medium (20%
potato extract liquid +2.0% dextrose +0.1% KH2PO4+
0.05% MgSO2). The culture was incubated at 27°C on a
rotary shaker at 180 rpm for 5 days.
A 120-h-old liquid culture was homogenized using
a sterilized blender and then inoculated to 500 mL
Erlenmeyer flasks containing 300 mL of fermented culture. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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then cultivated under the same condition. The 168-h-old
culture medium was used for extraction [7-9].
Triglycerides extracted from fermented mushroom of
coprinus comatus (TFC)
The methodology for extraction of triglycerides was
described in detail by Han et al. [10]. Briefly, mycelia were
separated from the culture fluid by filtration and extracted
twice with acetone in an ultrasonic bath. The extract was
filtered, and the acetone was removed in vacuo to yield an
aqueous residue. This residue was diluted with tap water
and subsequently extracted three times with EtOAc. The
combined organic phases were dried over Na2SO4 and
evaporated in vacuo to yield an oily residue.
Acute toxicity study
When there is no information of TFC on toxicity, it is
recommended to use the starting dose of 250 mg/kg
body weight. The animals were given intraperitoneally
the lowest with dose of 250 mg/kg of the compounds at
the first instance. If more than 50% mice die within
24 hrs, another group was chosen at a dose of 200 mg/kg.
If no death was observed, increasing dose up to limit
dose of 2,000 mg/kg was injected to the mice. If more than
50% death was observed in limit test, the dose was then
reduced to 800 mg/kg. Acute half lethal dose (LD50) was
determined after observing toxic reaction for three days.
Anti-inflammatory effect of TFC on cytokines levels
Wistar rats (weighing 225 ± 25 g) were used in the study.
This study was performed in accordance with the Guide
for the Care and Use of Laboratory Animals. The study
was approved by the ethics committee of Chinese Acad-
emy of Sciences, and all procedures complied with the
guidance set out in the Guidelines for Caring for Experi-
mental Animals published by the Ministry of Science
and Technology of the People's Republic of China. Care
was taken to minimize discomfort, distress, and pain to
the animals. Forty healthy female adult rats were ran-
domly divided in four groups. The TFC were presolubi-
lized in mixture of DMSO, ethanol and polysorbate-80.
This mixture was subsequently filled up with physio-
logical saline to final concentrations of 4% DMSO,Table 1 Effect of TFC on the Protein Levels of TNF-α, IL-1β, VE
Different groups TNF-α (pg/mL) IL-1β(p
Saline group 3021.0 ± 388.4 1066.6
Dic. group 1620.6 ± 118.0** 676.7 ±
TFC 10 group 2718.7 ± 370.2 1084.0
TFC 20 group 2013.4 ± 184.7 866.7 ±
TFC 30 group 1260.4 ± 195.5** 777.7 ±
Values are shown as means ± SEM. *p< 0.05 vs. Saline group, **p< 0.01 vs. Saline g10% ethanol and 20% polysorbate-80. Intraperitoneal
doses of 10, 20 and 30 mg/kg body weight were applied
in a volume of 2 ml/kg 1 h before the injection of carra-
geenan. Diclofenac sodium (1.7 mg/kg) was used as a
standard. Inflammatory response was induced by a single
intrapleural injection of 0.1 mLof sterile saline solution
(NaCl, 0.95%) plus carrageenan (Cg, 1%). Ten healthy
rats treated only with intrapleural injection (i.p.) of ster-
ile saline solution (NaCl 0.95%) used as control group.
Six hours after the injection of carrageenan, blood sam-
ples were drawn from orbital vein from all the groups
and serum was separated for biochemical estimations.
The level of TNF-α, IL-1β, VEGF-α, and IL-17 in the
rat blood samples were measured as previously described
by Cai et al. [11]. Briefly, protein was extracted from the
blood samples and the concentration was adjusted to
4 mg/ml. The concentration of TNF-α, IL-1β, VEGF-α,
and IL-17 were then determined using a commercial
ELISA kit (Shanghai Jinma Biological Technology, Inc.,
China) following the manufacture’s instruction.
Measurement of total antioxidant status
The total antioxidant status (TAOS) of serum was deter-
mined as previously described by Laight et al. [12]. The
increase of absorbance at 405 nm was measured by a
microplate reader (Shanghai Xunda Medical Technology,
Inc., China).
Peripheral antinociceptive effect of TFC in animal model
Kunming outbred mice weighing 20-22 g, were pur-
chased from the Experimental Animal Center, Shandong
University. The mice were maintained at room temperature
under alternating natural light/dark photoperiod, and had
access to standard laboratory food and fresh water ad
libitum.
Writhing test is used for the evaluation of peripheral
analgesic activity. Mice were treated (intraperitoneal)
with TFC of 10, 20 and 30 mg/kg body weight 60 min
before receiving a 0.6% acetic acid injection (10 mL/kg,
i.p.). The number of contractions or writhings, deter-
mined by abdominal muscle contractions and hind paw
extension was recorded for 20 min, starting 10 min after
the administration of acetic acid. Diclofenac sodium
(1.7 mg/kg) was used as standard.GF-α, and IL-17
g/mL) VEGF-α(pg/mL) IL-17(pg/mL)
± 148.8 1212.2 ± 117.7 867.1 ± 58.4
64.0 ** 675.5 ± 22.5 ** 91.5 ± 6.5***
± 84.3 1090.0 ± 44.1 771.7 ± 75.7
70.3 1054.4 ± 44.5 671.1 ± 35.5
66.3 * 648.0 ± 20.2 ** 93.5 ± 9.5***
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Figure 1 Effect of TFC on total antioxidant Activity. Values are
shown as means ± SEM. *p< 0.05 vs. Saline group, **p< 0.01 vs.
Saline group.
Table 3 Effect of TFC in mice subjected to the hot-plate
test. (N = 10)
Groups Reaction time to the thermal stimulus (s)
0 min 30 min 60 min 90 min
Saline group 10.9 ± 0.6 9.6 ± 0.9 8.3 ± 0.80 9.5 ± 0.6
Dic. group 9.9 ± 0.8 13.0 ± 1.1* 16.3 ± 0.6** 16.8 ± 1.5**
TFC 10 group 11.9 ± 1.5 11.4 ± 1.5 8.8 ± 1.2 11.4 ± 1.3
TFC 20 group 10.9 ± 2.2 11.5 ± 1.2 9.8 ± 1.1 10.6 ± 1.3
TFC 30 group 13.9 ± 1.1 11.2 ± 0.9 11.4 ± 1.7 12.5 ± 2.9
Values are shown as means ± SD.
*p< 0.05 vs. control group,**p< 0.01 vs. control group.
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The hot-plate test is commonly used to assess narcotic
analgesics or other centrally acting drugs [13,14]. In this
test, mice were pre-selected according to their reactions to
a thermal stimulus (jumping or licking of hind limbs when
placed on a hot plate at 55°C). Latency times were recorded
immediately before and 30, 60 and 90 min after drug ad-
ministration (intrapleural injection with TFC of 10, 20and
30 mg/kg body weight, diclofanac sodium 1.7 mg/kg and
sterile saline), up to a maximum time of 40 s to avoid paw
lesions [15].Anti-hyperalgesia effect of TFC in animal model
Mice received a single intraplantar injection of 100 μl of
1 mg/ml dose of heat-killed and dried Mycobacterium tu-
berculosis in a mixture of paraffin oil and mannide mono-
leate. The tactile hyperalgesia was tested as tactile
withdrawal threshold before and at 15, 30 and 60 min after
drug administration.Statistical analysis
The data were expressed as mean± S.E.M. and results
were analyzed by ANOVA followed by Dunnett’s t test.
P< 0.05 was considered significant.Table 2 Peripheral antinociceptive effect of TFC in mice
subjected to the writhing test




Saline group 25.1 ± 2.2 -
Dic. group 5.8 ± 1.9 76.9%
TFC 10 group 15.0 ± 2.1* 40.2%
TFC 20 group 7.6 ± 1.6** 69.7%
TFC 30 group 5.8 ± 1.2** 76.9%
Values are shown as means ± SEM. *p< 0.05 vs. Distilled water group, **p
<0.01 vs. Distilled water group (n = 10).Results and discussion
The present study demonstrates, for the first time, that
the anti-inflammatory and analgesic effects of TFC.
Carrageenan-induced inflammation in rats is a well-
characterized experimental model of acute inflammation
that permits the quantification and correlation of cellular
migration with changes in other inflammatory parameters
[16]. Diclofenac is a nonsteroidal anti-inflammatory
drug used to treat pain andinflammation associated with
arthritis. It was used as a standard. The inflammatory
response involves a complex intercellular signal promoting
cytokine release. Activated inflammatory cells synthesize
and secrete proinflammatory cytokines such as TNF-α,
IL-1β, VEGF-α, and IL-17 [17-19]. The suppression of
these proinflammatory mediators has been found to
reduce the severity of the inflammatory reaction [20].
Some work has been done on the effects of the mush-
room on cytokines and nuclear factor kappa B (NF-κB)
levels [21-25]. The present study was undertaken to de-
termine the effect of TFC on protein levels of TNF-α,
IL-1β, VEGF-α, and IL-17 during the inflammatory
process induced by carrageenan.
Treatment with TFC (30 m/kg) significantly reduced
the levels of TNF-α by 58.3% (P <0 .01), IL-1β by 27%
(P< 0.05),VEG F-α by 46.5% (P< 0.01) and IL-17 by
89.2% (P <0 .001), respectively (Table 1). Results of this
study clearly indicate the anti-inflammatory activity of
the TFC in acute inflammatory conditions. It could
effectively inhibit the leukocyte migration promoted by
carrageenan in rat.
O2
− has been associated with tissue damage and loss of
function during inflammatory episodes [26]. The total anti-
oxidant status (TAOS) is an indication of O2
− and other
oxidant species. We measured TAOS activity as an indirect
indication of the formation of O2
− and other oxidant spe-
cies. The TFC (10 m/kg) groups had the lower level of
TAOS activity in comparison to the saline group (P< 0.01)
(Figure 1). It is consistent with the previous report on the
antioxidant properties of Coprinus Comatus [27,28]. O2
− is
produced by polymorphonuclear leukocytes and macro-
































Figure 2 Effect of TFC on anti-hyperalgesia. Values are shown as means ± SEM. ***p< 0.0001 vs. Saline group.
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that TFC produce anti-inflammatory effect through
decreasing the levels of TAOS activities.
The report that no decrease in oedema induced by
formalin injection was observed following treatment with
C. comatus also showed that C. comatus had a periph-
eral antinociceptive and anti-inflammatory effect [29]. In
the writhing test, TFC inhibited the acetic acid-induced
abdominal constrictions in a dose-dependent manner
(40.2%, 69.7%, and 76.9%) (Table 2). The acetic acid-
induced writhing reaction in mice has been used as a
screening tool for the assessment of analgesic or anti-
inflammatory properties of new agents [30]. The con-
strictions induced by acetic acid in mice result from an
acute inflammatory reaction related to the increase in
the peritoneal fluid levels of PGE2 and PGF2α [31]. The
fact that TFC was able to inhibit constrictions showed
that TFC has a peripheral antinociceptive effect.
On the contrary, the result of the hot-plate test did
not show that TFC has a central antinociceptive effect.
The hot-plate test is commonly used to assess narcotic
analgesics or other centrally acting drugs [13,14]. The
hot-plate test was performed for the assessment of the
central antinociceptive effect of TFC in this study.
Results showed that TFC inhibited the reaction time to
thermal stimuli at 30, 60, and 90 min compared to
controls. However, it was not significant (Table 3). The
mechanism of TFC does not exert central antinocicep-
tive effect could be explained that it has poor permeabil-
ity across the blood brain barrier (BBB). BBB is an active
interface between the circulation and the central ner-
vous system (CNS) which restricts the free movement of
different substances between the two compartments and
plays a crucial role in the maintenance of the homeosta-
sis of the CNS [32].
Complete Freund’s adjuvant (CFA) -induced hyperalge-
sia is frequently used as an animal model to study
chronic inflammatory pain. The CFA-induced inflamma-
tion is accompanied by a tactile hyperalgesia (HA), which
is robust over several days [33]. TFC reduced dose-
dependently the CFA-induced tactile hyperalgesia(Figure 2). It is likely that the antihyperalgesic effect of
CFA was due to a genuine anti-inflammatory effect.
As per the OECD Guidelines-423, LD50 was calculated
for TFC. When there is no information of TFC on toxicity,
it is recommended to use the starting dose of 250 mg/kg
body weight. This involves the estimation of the median
lethal dose (LD50), which is the dose that will kill 50% of the
animal population within 72 hours post treatment with the
test substance. After intraperitoneal injection, most mice in
the 400 mg/kg group were quiet and inactive. Mice died ap-
proximately 7 hr after injection. The majority of mice in the
400 mg/kg dose group (5 mice) died within 72 hr following
the injection. The LD50 was determined to be 400 mg/kg.
Conclusion
In conclusion, TFC showed anti-inflammatory, antioxi-
dant, peripheral antinociceptive and antihyperalgesic
activity in various models of inflammatory pain. The data
suggest that TFC may be a viable treatment option for
inflammatory pain.
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